Alcis Daily Relief Pain Relief

Product NDC: 58132-3331
11-digit product format: 581323331
Labeler code: 58132
Product ID: 58132-3331_c2b362c3-36dc-40ef-91be-242d45a09b47
Type: HUMAN OTC DRUG
Nonproprietary name: Trolamine Salicylate
Dosage form: CREAM
Route: TOPICAL
Labeler: Alcis Topical, Inc.
Application: part348
Marketing category: OTC MONOGRAPH NOT FINAL
Marketing start: 2009-03-09
Marketing end: 0000-00-00
Substance: TROLAMINE SALICYLATE
Active strength: 10 g/100mL
NDC exclude flag: E
Listing certified through: 2018-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	58132-3331		I	Inactivated by FDA	2026-08-11
excluded package	package	58132-3331	58132-3331-2	I	Inactivated by FDA	2026-08-11
excluded package	package	58132-3331	58132-3331-3	I	Inactivated by FDA	2026-08-11

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 66 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	58132-3331-3	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	58132-3331-2	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	58132-3331-3	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	58132-3331-2	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	58132-3331-3	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	58132-3331-2	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	58132-3331-3	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	58132-3331-2	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	58132-3331-3	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	58132-3331-2	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	58132-3331-3	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	58132-3331-2	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	58132-3331-3	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	58132-3331-2	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	58132-3331-3	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	58132-3331-2	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	58132-3331-3	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	58132-3331-2	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	58132-3331-3	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	58132-3331-2	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	58132-3331-3	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	58132-3331-2	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	58132-3331-3	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	58132-3331-2	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	58132-3331-3	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	58132-3331-2	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	58132-3331-3	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	58132-3331-2	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	58132-3331-3	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	58132-3331-2	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	58132-3331-3	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	58132-3331-2	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	58132-3331-3	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	58132-3331-2	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	58132-3331-3	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	58132-3331-2	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	58132-3331-3	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	58132-3331-2	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	58132-3331-3	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	58132-3331-2	`e2bbac7714bc…`	`27bdfed8d636…`

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
58132-3331-2	2020-01-31	C162847	48780-1	9d75b9d0-7684-f424-e053-dadaa90a57ce	Drug Facts
58132-3331-3	2020-01-31	C162847	48780-1	9d75b9d0-7684-f424-e053-dadaa90a57ce	Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
58132-3331-2	Alcis Daily Relief Pain Relief	59.1 mL in 1 TUBE	CREAM	59.1	2
58132-3331-2	Alcis Daily Relief Pain Relief	1 in 1 CARTON	CREAM	1	2
58132-3331-3	Alcis Daily Relief Pain Relief	88.7 mL in 1 TUBE	CREAM	88.7	2
58132-3331-3	Alcis Daily Relief Pain Relief	1 in 1 CARTON	CREAM	1	2

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
TROLAMINE SALICYLATE	ACTIVE INGREDIENT	H8O4040BHD	ALCIS DAILY RELIEF PAIN RELIEF (TROLAMINE SALICYLATE) CREAM [ALCIS TOPICAL, INC.]	2
SALICYLIC ACID	ACTIVE MOIETY	O414PZ4LPZ	ALCIS DAILY RELIEF PAIN RELIEF (TROLAMINE SALICYLATE) CREAM [ALCIS TOPICAL, INC.]	2
.ALPHA.-TOCOPHEROL ACETATE	INACTIVE INGREDIENT	9E8X80D2L0	ALCIS DAILY RELIEF PAIN RELIEF (TROLAMINE SALICYLATE) CREAM [ALCIS TOPICAL, INC.]	2
CAMELLIA OLEIFERA LEAF	INACTIVE INGREDIENT	5077EL0C60	ALCIS DAILY RELIEF PAIN RELIEF (TROLAMINE SALICYLATE) CREAM [ALCIS TOPICAL, INC.]	2
CETYL ALCOHOL	INACTIVE INGREDIENT	936JST6JCN	ALCIS DAILY RELIEF PAIN RELIEF (TROLAMINE SALICYLATE) CREAM [ALCIS TOPICAL, INC.]	2
CHAMOMILE	INACTIVE INGREDIENT	FGL3685T2X	ALCIS DAILY RELIEF PAIN RELIEF (TROLAMINE SALICYLATE) CREAM [ALCIS TOPICAL, INC.]	2
CYCLOMETHICONE	INACTIVE INGREDIENT	NMQ347994Z	ALCIS DAILY RELIEF PAIN RELIEF (TROLAMINE SALICYLATE) CREAM [ALCIS TOPICAL, INC.]	2
DIMETHICONE	INACTIVE INGREDIENT	92RU3N3Y1O	ALCIS DAILY RELIEF PAIN RELIEF (TROLAMINE SALICYLATE) CREAM [ALCIS TOPICAL, INC.]	2
DIMETHYL SULFONE	INACTIVE INGREDIENT	9H4PO4Z4FT	ALCIS DAILY RELIEF PAIN RELIEF (TROLAMINE SALICYLATE) CREAM [ALCIS TOPICAL, INC.]	2
EDETATE DISODIUM	INACTIVE INGREDIENT	7FLD91C86K	ALCIS DAILY RELIEF PAIN RELIEF (TROLAMINE SALICYLATE) CREAM [ALCIS TOPICAL, INC.]	2
GLUCOSAMINE SULFATE	INACTIVE INGREDIENT	1FW7WLR731	ALCIS DAILY RELIEF PAIN RELIEF (TROLAMINE SALICYLATE) CREAM [ALCIS TOPICAL, INC.]	2
GLYCERYL DISTEARATE	INACTIVE INGREDIENT	73071MW2KM	ALCIS DAILY RELIEF PAIN RELIEF (TROLAMINE SALICYLATE) CREAM [ALCIS TOPICAL, INC.]	2
GLYCERYL MONOSTEARATE	INACTIVE INGREDIENT	230OU9XXE4	ALCIS DAILY RELIEF PAIN RELIEF (TROLAMINE SALICYLATE) CREAM [ALCIS TOPICAL, INC.]	2
IMIDUREA	INACTIVE INGREDIENT	M629807ATL	ALCIS DAILY RELIEF PAIN RELIEF (TROLAMINE SALICYLATE) CREAM [ALCIS TOPICAL, INC.]	2
LAVANDULA ANGUSTIFOLIA FLOWERING TOP	INACTIVE INGREDIENT	9YT4B71U8P	ALCIS DAILY RELIEF PAIN RELIEF (TROLAMINE SALICYLATE) CREAM [ALCIS TOPICAL, INC.]	2
MEDIUM-CHAIN TRIGLYCERIDES	INACTIVE INGREDIENT	C9H2L21V7U	ALCIS DAILY RELIEF PAIN RELIEF (TROLAMINE SALICYLATE) CREAM [ALCIS TOPICAL, INC.]	2
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	ALCIS DAILY RELIEF PAIN RELIEF (TROLAMINE SALICYLATE) CREAM [ALCIS TOPICAL, INC.]	2
PEG-100 STEARATE	INACTIVE INGREDIENT	YD01N1999R	ALCIS DAILY RELIEF PAIN RELIEF (TROLAMINE SALICYLATE) CREAM [ALCIS TOPICAL, INC.]	2
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	ALCIS DAILY RELIEF PAIN RELIEF (TROLAMINE SALICYLATE) CREAM [ALCIS TOPICAL, INC.]	2
POLYETHYLENE GLYCOL 600	INACTIVE INGREDIENT	NL4J9F21N9	ALCIS DAILY RELIEF PAIN RELIEF (TROLAMINE SALICYLATE) CREAM [ALCIS TOPICAL, INC.]	2
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	ALCIS DAILY RELIEF PAIN RELIEF (TROLAMINE SALICYLATE) CREAM [ALCIS TOPICAL, INC.]	2
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	ALCIS DAILY RELIEF PAIN RELIEF (TROLAMINE SALICYLATE) CREAM [ALCIS TOPICAL, INC.]	2
ROSEMARY	INACTIVE INGREDIENT	IJ67X351P9	ALCIS DAILY RELIEF PAIN RELIEF (TROLAMINE SALICYLATE) CREAM [ALCIS TOPICAL, INC.]	2
SODIUM METABISULFITE	INACTIVE INGREDIENT	4VON5FNS3C	ALCIS DAILY RELIEF PAIN RELIEF (TROLAMINE SALICYLATE) CREAM [ALCIS TOPICAL, INC.]	2
STEARYL ALCOHOL	INACTIVE INGREDIENT	2KR89I4H1Y	ALCIS DAILY RELIEF PAIN RELIEF (TROLAMINE SALICYLATE) CREAM [ALCIS TOPICAL, INC.]	2
VITIS VINIFERA SEED	INACTIVE INGREDIENT	C34U15ICXA	ALCIS DAILY RELIEF PAIN RELIEF (TROLAMINE SALICYLATE) CREAM [ALCIS TOPICAL, INC.]	2
WATER	INACTIVE INGREDIENT	059QF0KO0R	ALCIS DAILY RELIEF PAIN RELIEF (TROLAMINE SALICYLATE) CREAM [ALCIS TOPICAL, INC.]	2
XANTHAN GUM	INACTIVE INGREDIENT	TTV12P4NEE	ALCIS DAILY RELIEF PAIN RELIEF (TROLAMINE SALICYLATE) CREAM [ALCIS TOPICAL, INC.]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
58132-3331	ALCIS DAILY RELIEF PAIN RELIEF (TROLAMINE SALICYLATE) CREAM [ALCIS TOPICAL, INC.]	2	Legacy NDC, 4 package rows	20140207_b5b1f3a2-7fba-4c2e-aee9-a0bf28ae1364.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
H8O4040BHD	TROLAMINE SALICYLATE	2174-16-5	TROLAMINE SALICYLATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
313518	trolamine salicylate 10 % Topical Cream	PSN	b5b1f3a2-7fba-4c2e-aee9-a0bf28ae1364	2
313518	trolamine salicylate 100 MG/ML Topical Cream	SCD	b5b1f3a2-7fba-4c2e-aee9-a0bf28ae1364	2
313518	trolamine salicylate 10 % Topical Cream	SY	b5b1f3a2-7fba-4c2e-aee9-a0bf28ae1364	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
58132-3331-2	58132333102	59.1 mL in 1 TUBE	59.1 ml	Historical
58132-3331-3	58132333103	88.7 mL in 1 TUBE	88.7 ml	Historical